Stifel Nicolaus restated their hold rating on shares of Medical Properties Trust, Inc. (NYSE:MPW) in a research report report published on Friday morning. The firm currently has a $13.00 target price on the real estate investment trust’s stock.

MPW has been the topic of a number of other research reports. ValuEngine lowered Medical Properties Trust from a buy rating to a hold rating in a report on Friday, June 2nd. Zacks Investment Research raised Medical Properties Trust from a hold rating to a buy rating and set a $15.00 price target on the stock in a report on Wednesday, July 19th. JMP Securities raised Medical Properties Trust from a market perform rating to an outperform rating and set a $14.00 price target on the stock in a report on Monday, July 17th. They noted that the move was a valuation call. BidaskClub raised Medical Properties Trust from a sell rating to a hold rating in a report on Saturday, June 10th. Finally, Jefferies Group LLC raised Medical Properties Trust from a hold rating to a buy rating and lifted their price objective for the company from $13.00 to $15.00 in a report on Friday, April 7th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the stock. Medical Properties Trust presently has a consensus rating of Hold and a consensus price target of $14.20.

Shares of Medical Properties Trust (NYSE:MPW) opened at 12.98 on Friday. Medical Properties Trust has a 52 week low of $11.54 and a 52 week high of $15.74. The stock has a market cap of $4.17 billion, a P/E ratio of 15.58 and a beta of 0.89. The stock has a 50 day moving average price of $12.98 and a 200-day moving average price of $13.05.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.33. Medical Properties Trust had a return on equity of 7.94% and a net margin of 41.79%. The firm had revenue of $156.40 million for the quarter, compared to analyst estimates of $156.91 million. During the same quarter last year, the company posted $0.35 earnings per share. The business’s revenue was up 15.9% on a year-over-year basis. Equities analysts predict that Medical Properties Trust will post $0.87 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Medical Properties Trust, Inc. (NYSE:MPW) Earns Hold Rating from Stifel Nicolaus” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.watchlistnews.com/medical-properties-trust-inc-nysempw-earns-hold-rating-from-stifel-nicolaus/1465353.html.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 14th. Investors of record on Thursday, June 15th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Tuesday, June 13th. This represents a $0.96 annualized dividend and a dividend yield of 7.40%. Medical Properties Trust’s dividend payout ratio is currently 114.29%.

In related news, CFO R Steven Hamner sold 85,000 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total transaction of $1,135,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.00% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. State of Alaska Department of Revenue increased its position in shares of Medical Properties Trust by 35.0% in the first quarter. State of Alaska Department of Revenue now owns 160,060 shares of the real estate investment trust’s stock valued at $2,062,000 after buying an additional 41,530 shares in the last quarter. Huntington National Bank increased its position in shares of Medical Properties Trust by 70.1% in the first quarter. Huntington National Bank now owns 11,434 shares of the real estate investment trust’s stock valued at $147,000 after buying an additional 4,712 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Medical Properties Trust by 10.0% in the first quarter. Nisa Investment Advisors LLC now owns 78,040 shares of the real estate investment trust’s stock valued at $1,006,000 after buying an additional 7,090 shares in the last quarter. Capital Impact Advisors LLC increased its position in shares of Medical Properties Trust by 92.8% in the first quarter. Capital Impact Advisors LLC now owns 141,019 shares of the real estate investment trust’s stock valued at $1,818,000 after buying an additional 67,894 shares in the last quarter. Finally, Louisiana State Employees Retirement System increased its position in shares of Medical Properties Trust by 2.3% in the first quarter. Louisiana State Employees Retirement System now owns 81,000 shares of the real estate investment trust’s stock valued at $1,044,000 after buying an additional 1,800 shares in the last quarter. Hedge funds and other institutional investors own 78.58% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.